Browse the evidence

Tirzepatide had superiority over placebo or other antidiabetic agents in controlling lipid and waist circumference levels.

Tirzepatide may be a preferred treatment option for improving lipid profiles and waist circumference in patients with type 2 diabetes.

Mean 12-month weight loss was -2.4 kg.

Practitioners can expect an average weight loss of about 2.4 kg in similar interventions.

At 42 months, participants regained weight but did not exceed baseline, with a mean change of -0.5 kg.

Long-term maintenance strategies can help prevent exceeding initial weight after loss.

Improvements in triglycerides were completely sustained at 42 months.

Sustained improvements in triglycerides suggest effective long-term health benefits from the intervention.

Extreme intakes of macronutrients may be associated with health risks.

Practitioners should advise moderation in macronutrient intake to avoid potential health risks.

People with fourth and fifth quintiles of total energy intake are likely to have lower risks of all-cause and expanded cardiovascular disease (CVD) mortality.

Increasing total energy intake within certain limits may be beneficial for longevity in type 2 diabetes patients.

People with fifth quintiles of total energy intake are likely to have decreased non-expanded CVD mortality.

Higher total energy intake may reduce the risk of non-expanded CVD mortality in type 2 diabetes patients.

Fat intake was associated with all-cause, expanded and non-expanded CVD mortality among males with T2DM.

Monitoring fat intake may be important for reducing mortality risk in male patients with type 2 diabetes.

Excess weight and elevated Body Mass Index are associated with lower adherence to the Mediterranean diet.

Addressing weight issues may improve adherence to the Mediterranean diet.

After educational intervention, adherence to the Mediterranean diet increased from a score of 6.22 to 6.84.

Educational programs can effectively enhance adherence to the Mediterranean diet.

Four positive signals were found at the system organ classes level for tirzepatide.

Monitoring for specific adverse events is crucial for patients on tirzepatide.

Two patients achieved significant weight loss of 16% and 12.6% in under 9 months using semaglutide.

Clinicians can expect significant weight loss outcomes in similar patients using semaglutide.

There are physiological and behavioral barriers to exercise that people with diabetes must overcome.

Addressing these barriers is crucial for effective exercise interventions.

There is variability in the adaptive response to exercise by sex, genetics, and environment.

Personalized exercise programs may be necessary to account for individual variability.

The presence of NAFLD is associated with severe liver complications and increased mortality from cardiovascular disease.

Primary care providers should monitor cardiovascular health in patients with NAFLD.

DTC fitness genetic tests promise insights about nutrition, healthy aging, weight loss, and athletic aptitude.

Consumers should critically evaluate the claims made by DTC fitness genetic tests.

Individuals with obesity are at greater risk for developing metabolic diseases such as type 2 diabetes, metabolic dysfunction-associated steatohepatitis, and cardiovascular diseases.

Healthcare providers should monitor metabolic health in patients with obesity.

GLP-1RA use in MUHO is associated with a lower risk of ischemic stroke (HR 0.921) compared to non-use.

GLP-1RAs may be beneficial for reducing ischemic stroke risk in MUHO patients.

Patients with metabolically healthy obesity (MHO) have a markedly lower risk of clinical events compared to those with metabolically unhealthy obesity (MUHO).

Understanding the risk differences can guide treatment decisions for obesity management.

The use of Kaupapa Māori principles contributed to improvements in physical and mental wellbeing.

Incorporating cultural values into fitness programmes can enhance participant wellbeing.

Most ultraprocessed foods overlap with foods high in saturated fat, added sugars, and sodium.

Practitioners should consider the nutritional content of UPFs when advising clients.

52.4% of powerlifters reported stretching, with 84.4% performing static stretches and 90.4% performing dynamic stretches.

Coaches and athletes should be aware that a significant portion of powerlifters engage in stretching, particularly static and dynamic forms.

77.8% of powerlifters performed stretching before resistance training.

It is common practice among powerlifters to incorporate stretching before their training sessions.

66.9% of powerlifters programmed stretching themselves.

Powerlifters often take initiative in planning their own stretching routines, which may influence their training outcomes.